Moneycontrol

Budget 2023Budget 2023

PARTNERS

  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
  • SMC Global Securities Limited
  • SBI Life
  • DSP Mutual Fund
Upcoming Event : LeapToUnicorn - mentoring, networking and fundraising for startups. Register now
you are here: HomeNewsBusinessIPO

Gland Pharma IPO day 1: Issue subscribed 4.5%, retail portion booked 7.7%

The Rs 6,480-crore IPO of Gland Pharma consists a fresh issue of Rs 1,250 crore and an offer for sale of over 3.48 crore equity shares by promoters and selling shareholders

November 09, 2020 / 05:40 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

The Rs 6,480-crore IPO of Gland Pharma, will be the only listed player in the pure formulations space in India, has subscribed 4.5 percent on November 9, the first day of bidding.

The public issue has received bids for 12.69 lakh equity shares against IPO size of over 3.02 crore equity shares, the data available on the exchanges showed.

The IPO size excludes anchor book portion of over 1.29 crore equity shares as the company has already garnered Rs 1,944 crore from 70 anchor investors on November 6, a day before the issue opened.

Gland Pharma IPO: 10 key things you should know before subscribing